Theatre
Genentech defends breast cancer drug a decade after Avastin drama
Genentech Inc. likely will get another chance to build the scientific proof that its drug targeting a type of breast cancer actually extends patients' lives.
Genentech Inc. likely will get another chance to build the scientific proof that its drug targeting a type of breast cancer actually extends patients' lives.
